Zobrazeno 1 - 10
of 15
pro vyhledávání: '"S. Polta"'
Publikováno v:
MethodsX, Vol 2, Iss C, Pp 232-240 (2015)
Studying sleep behavior in animal models demands clear separation of vigilance states. Pure manual scoring is time-consuming and commercial scoring software is costly. We present a LabVIEW-based, semi-automated scoring routine using recorded EEG and
Externí odkaz:
https://doaj.org/article/fbf0794ace2847e4aca154bdbfa06dce
Publikováno v:
MethodsX
METHODSX
MethodsX, Vol 2, Iss C, Pp 232-240 (2015)
METHODSX
MethodsX, Vol 2, Iss C, Pp 232-240 (2015)
Graphical abstract
Studying sleep behavior in animal models demands clear separation of vigilance states. Pure manual scoring is time-consuming and commercial scoring software is costly. We present a LabVIEW-based, semi-automated scoring routine
Studying sleep behavior in animal models demands clear separation of vigilance states. Pure manual scoring is time-consuming and commercial scoring software is costly. We present a LabVIEW-based, semi-automated scoring routine
Publikováno v:
European Journal of Anaesthesiology. 30:110-111
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the Pakistan Medical Association; Jul2022, Vol. 72 Issue 7, p1340-1344, 5p
Autor:
Mines, Richard O.
Publikováno v:
Journal of Environmental Science & Health. Part A. Toxic/Hazardous Substances & Environmental Engineering; 2020, Vol. 55 Issue 4, p345-353, 9p
Publikováno v:
Analyst; Jul1994, Vol. 119 Issue 7, p1607-1612, 6p
Autor:
Okuyama, Atsushi, Otaka, Michiro, Otani, Setsuya, Jin, Mario, Fujimori, Shusei, Itoh, Hideaki, Tashima, Yohtalou, Masamune, Osamu
Publikováno v:
Journal of Gastroenterology; Jan1996, Vol. 31 Issue 1, p143-145, 3p
Autor:
G. Casella, Innocenzo
Publikováno v:
Analyst; Jun1998, Vol. 123 Issue 6, p1359-1363, 1p
Autor:
Nancy B. Cummings, S. Klahr
Chronic renal disease has received increasing attention and concern since the passage in 1972 of PL 92-603, which provided coverage for end-stage renal disease (ESRD) treatment by the federal government. The human and economic costs of the ESRD progr